News

Obesity drug endorsed by NICE

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7287.637/b (Published 17 March 2001) Cite this as: BMJ 2001;322:637
  1. Jacqui Wise
  1. London

    The anti-obesity drug orlistat (Xenical) should be available throughout England and Wales on the NHS, the government's drug advisory body has recommended. The decision by the National Institute for Clinical Excellence (NICE) should put an end to “postcode prescribing,” which has led to a 16-fold difference between the areas where it is most commonly prescribed and the areas where it is least prescribed.

    The institute sets outs strict guidelines for prescribing orlistat as one part of the management of obesity. It should be prescribed only to adults (aged 18 to 75 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe